2025-521771-31-00招募中1 期
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 12
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Prof. dr. H.W. Nijman
Scientific
Universitair Medisch Centrum Groningen
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
A Phase I/II Study of Immunotherapy with Subcutaneous Administered Veltuzumab (hA20) in Patients with CD20+ Non-Hodgkin's Lymphoma or Chronic Lyphocytic LeukemiaEUCTR2008-000434-47-FRImmunomedics, Inc.46
进行中（未招募）
1 期
Treatment with daratumumab injections in moderate to severe ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 20.1Level: LLTClassification code 10028414Term: Myalgic encephalomyelitisSystem Organ Class: 100000004862EUCTR2022-000281-18-NOHaukeland University Hospital, Dept. of Oncology and Medical Physics10
进行中（未招募）
1 期
Daratumumab in ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 26.1Level: LLTClassification code: 10028414Term: Myalgic encephalomyelitis Class: 10021881CTIS2024-512500-19-00Helse Bergen HF10
招募中
2 期
A Study of Ketamine in Elderly Patients with Depression.DepressionACTRN12617001130358niversity of Otago24
已完成
不适用
Phase I / II study of intracutaneous inoculation of COVID-19 DNA vaccine (AG0302-COVID19)jRCT205120008520